Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ensign GroupMIL:1ENSG 74 3-Year RORE % is 13.59 as of Jun. 2026. GuruFocus rates MIL:1ENSG with a GF Score™ of 74/100 and a GF Value™ of €163.89 (Fairly Valued). The stock has 3 warning signs investors should review. Among 601 Healthcare Providers & Services companies, Ensign Group ranks better than 66.89% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Ensign Group's 3-Year RORE % for the quarter that ended in Jun. 2026 was 13.59%.
The industry rank for Ensign Group's 3-Year RORE % or its related term are showing as below:
MIL:1ENSG's 3-Year RORE % is ranked better than 66.89% of 601
companies
in the Healthcare Providers & Services industry
Industry Median: 0.38
vs MIL:1ENSG: 13.59
Ensign Group (MIL:1ENSG) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Ensign Group 3-Year RORE % Related Terms
Ensign Group 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Ensign Group's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1ENSG vs UHS, EHC, PACS: 3-Year RORE % Comparison
For the Medical Care Facilities subindustry, Ensign Group's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ensign Group 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ensign Group's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Ensign Group's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2026 and 3-year before.
Ensign Group (MIL:1ENSG) has a 3-Year RORE % of 13.59 as of Jun. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Ensign Group and its competitors. According to the industry distribution chart, Ensign Group ranks #199 out of 601 companies in the Healthcare Providers & Services industry, placing it in the top 33.1%.
Is Ensign Group's 3-Year RORE % too high?
Ensign Group's current 3-Year RORE % is 13.59. The Healthcare Providers & Services industry median 3-Year RORE % is 0.38. Ensign Group's value of 13.59 is 3476.3% above this industry median. Based on the distribution chart, Ensign Group ranks #199 out of 601 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ensign Group has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ensign Group's 3-Year RORE % compare to UHS and EHC?
According to the Healthcare Providers & Services industry distribution chart, Ensign Group ranks #199 out of 601 companies for 3-Year RORE %. This puts Ensign Group in the upper half of its industry. The industry median 3-Year RORE % is 0.38. Ensign Group's value of 13.59 is 3476.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.38, based on 601 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ensign Group's current 3-Year RORE % of 13.59 is 3476.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Ensign Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ensign Group's current 3-Year RORE % is 13.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ensign Group stock overvalued right now?
Based on GuruFocus' analysis, Ensign Group (MIL:1ENSG) is currently considered Fairly Valued. The stock's GF Value™ is €163.89, compared to a current price of €152.60 — trading 6.9% below its estimated fair value. The current 3-Year RORE % is 13.59 and 3476.3% above the Healthcare Providers & Services industry median of 0.38. Ensign Group's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Ensign Group (MIL:1ENSG), the current 3-Year RORE % is 13.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ensign Group (MIL:1ENSG) Overvalued in 2026?
Based on GuruFocus' analysis, Ensign Group stock appears to be undervalued.
The current stock price of €152.60 is trading 6.9% below its estimated GF Value™ of €163.89.
GuruFocus considers Ensign Group to be Fairly Valued.
Key valuation signals for MIL:1ENSG:
3-Year RORE %: 13.59
GF Value™: €163.89 vs. price of €152.60 (6.9% below fair value)
Industry Position: 3476.3% above the Healthcare Providers & Services median (#199 of 601)
No single metric tells the full story. See the MIL:1ENSG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
74GF Score
Get the complete analysis for MIL:1ENSG
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1ENSG has been successfully added to your 
